{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:11Z","timestamp":1786995671108,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFA0502304"],"award-info":[{"award-number":["2016YFA0502304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673356"],"award-info":[{"award-number":["81673356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"111 Project","doi-asserted-by":"crossref","award":["B0702"],"award-info":[{"award-number":["B0702"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Heart, Lung, and Blood Institute of the National Institutes of Health","award":["K99HL138272"],"award-info":[{"award-number":["K99HL138272"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.phrs.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T15:46:46Z","timestamp":1510328806000},"page":"400-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches"],"prefix":"10.1016","volume":"129","author":[{"given":"Zengrui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianduanyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hankun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.005_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrd3859","article-title":"The GPCR Network: a large-scale collaboration to determine human GPCR structure and function","volume":"12","author":"Stevens","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.005_bib0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tips.2014.10.009","article-title":"Computational studies to predict or explain G protein coupled receptor polypharmacology","volume":"35","author":"Jacobson","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.005_bib0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.tips.2016.09.009","article-title":"Successful strategies to determine high-resolution structures of GPCRs","volume":"37","author":"Xiang","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.005_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.005_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd.2015.4","article-title":"G protein-coupled receptors as targets for anti-diabetic therapeutics","volume":"15","author":"Oh","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.phrs.2017.11.005_bib0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.005_bib0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nbt1228","article-title":"Global mapping of pharmacological space","volume":"24","author":"Paolini","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.phrs.2017.11.005_bib0050","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","article-title":"Drug-target network","volume":"25","author":"Yildirim","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"9\u201310","key":"10.1016\/j.phrs.2017.11.005_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"19","key":"10.1016\/j.phrs.2017.11.005_bib0060","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.drudis.2015.12.007","article-title":"In silico methods to address polypharmacology: current status, applications and future perspectives","volume":"21","author":"Lavecchia","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"7428","key":"10.1016\/j.phrs.2017.11.005_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"7403","key":"10.1016\/j.phrs.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11159","article-title":"Large-scale prediction and testing of drug activity on side-effect targets","volume":"486","author":"Lounkine","year":"2012","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.phrs.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2174\/1568026616666160530181149","article-title":"Molecular docking for identification of potential targets for drug repurposing","volume":"16","author":"Luo","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"30","key":"10.1016\/j.phrs.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.2174\/1568026616666160530181328","article-title":"Drug repositioning through network pharmacology","volume":"16","author":"Ye","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jamia\/ocw007","article-title":"A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes","volume":"23","author":"Cheng","year":"2016","journal-title":"J. Am. Med. Inf. Assoc."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0100","first-page":"682","article-title":"Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era","volume":"18","author":"Cheng","year":"2017","journal-title":"Brief. Bioinform."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/acs.jmedchem.6b01507","article-title":"Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis","volume":"60","author":"Lu","year":"2017","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/ci400010x","article-title":"Prediction of polypharmacological profiles of drugs by the integration of chemical: side effect, and therapeutic space","volume":"53","author":"Cheng","year":"2013","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2217\/bmm.15.81","article-title":"Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science","volume":"9","author":"Zhang","year":"2015","journal-title":"Biomark. Med."},{"key":"10.1016\/j.phrs.2017.11.005_bib0120","first-page":"58114","article-title":"FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach","author":"Lu","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2012.03.007","article-title":"Structure-based drug screening for G-protein-coupled receptors","volume":"33","author":"Shoichet","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2017.11.005_bib0130","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1039\/c2mb25110h","article-title":"Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods","volume":"8","author":"Cheng","year":"2012","journal-title":"Mol. Biosyst."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0135","doi-asserted-by":"crossref","first-page":"e1002503","DOI":"10.1371\/journal.pcbi.1002503","article-title":"Prediction of drug-target interactions and drug repositioning via network-based inference","volume":"8","author":"Cheng","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.005_bib0140","doi-asserted-by":"crossref","first-page":"e41064","DOI":"10.1371\/journal.pone.0041064","article-title":"Prediction of chemical-protein interactions network with weighted network-based inference method","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.11.005_bib0145","first-page":"45576","article-title":"Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology","author":"Li","year":"2014","journal-title":"Sci. Rep."},{"issue":"29","key":"10.1016\/j.phrs.2017.11.005_bib0150","doi-asserted-by":"crossref","first-page":"45584","DOI":"10.18632\/oncotarget.10052","article-title":"Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.phrs.2017.11.005_bib0155","first-page":"333","article-title":"SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning","volume":"18","author":"Wu","year":"2017","journal-title":"Brief. Bioinform."},{"issue":"23","key":"10.1016\/j.phrs.2017.11.005_bib0160","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1111\/bph.13629","article-title":"In silico prediction of chemical mechanism of action via an improved network-based inference method","volume":"173","author":"Wu","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.7b00216","article-title":"Quantitative and systems pharmacology. 1. In silico prediction of drug-target interaction of natural products enables new targeted cancer therapy","author":"Fang","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"D1","key":"10.1016\/j.phrs.2017.11.005_bib0170","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkt1143","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands","volume":"42","author":"Pawson","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.phrs.2017.11.005_bib0175","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/bioinformatics\/btv302","article-title":"GLASS: a comprehensive database for experimentally validated GPCR-ligand associations","volume":"31","author":"Chan","year":"2015","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.phrs.2017.11.005_bib0180","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2017.11.005_bib0185","doi-asserted-by":"crossref","first-page":"D115","DOI":"10.1093\/nar\/gkh131","article-title":"UniProt: the universal protein knowledgebase","volume":"32","author":"Apweiler","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2017.11.005_bib0190","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/107385840000600408","article-title":"The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches?","volume":"6","author":"Roth","year":"2000","journal-title":"Neuroscientist"},{"key":"10.1016\/j.phrs.2017.11.005_bib0200","first-page":"314","article-title":"Open babel: an open chemical toolbox","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.phrs.2017.11.005_bib0205","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.005_bib0210","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.005_bib0215","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"9896","key":"10.1016\/j.phrs.2017.11.005_bib0220","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.phrs.2017.11.005_bib0225","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1021\/jm400856t","article-title":"Polypharmacology \u2013 foe or friend?","volume":"56","author":"Peters","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.005_bib0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline: duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2017.11.005_bib0235","first-page":"21","article-title":"Antidepressants as analgesics: an overview of central and peripheral mechanisms of action","volume":"26","author":"Sawynok","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2017.11.005_bib0240","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","article-title":"Domperidone: review of pharmacology and clinical applications in gastroenterology","volume":"102","author":"Reddymasu","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.phrs.2017.11.005_bib0245","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/bioinformatics\/btn479","article-title":"Chemical substructures that enrich for biological activity","volume":"24","author":"Klekota","year":"2008","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0250","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/ci4000079","article-title":"Adverse drug events: database construction and in silico prediction","volume":"53","author":"Cheng","year":"2013","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.005_bib0255","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCRESAHA.107.167783","article-title":"A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy","volume":"102","author":"Zhang","year":"2008","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0260","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1242\/dmm.010967","article-title":"Muscarinic cholinergic receptor (M-2) plays a crucial role in the development of myopia in mice","volume":"6","author":"Barathi","year":"2013","journal-title":"Dis. Models Mech."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0705636","article-title":"Modulation of the baroreceptor reflex by alpha(2A)-adrenoceptors: a study in alpha(2A) knockout mice","volume":"141","author":"Niederhoffer","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2017.11.005_bib0270","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2007.09.069","article-title":"Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome","volume":"51","author":"Schwartz","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.005_bib0275","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/pr.112.007195","article-title":"The prostanoid EP4 receptor and its signaling pathway","volume":"65","author":"Yokoyama","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.005_bib0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pharmthera.2013.03.006","article-title":"E-type prostanoid receptor 4 (EP4) in disease and therapy","volume":"138","author":"Konya","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.phrs.2017.11.005_bib0285","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1158\/0008-5472.CAN-06-1271","article-title":"Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0290","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1541-7786.MCR-09-0511","article-title":"Prostaglandin E-2 promotes lung cancer cell migration via EP4-beta Arrestin1-c-Src signalsome","volume":"8","author":"Il Kim","year":"2010","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.005_bib0295","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.062053399","article-title":"Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation","volume":"99","author":"Yoshida","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.005_bib0300","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1476-5381.2010.00647.x","article-title":"A novel antagonist of the prostaglandin E-2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models","volume":"160","author":"Chen","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.005_bib0305","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-Family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.005_bib0310","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","article-title":"A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model","volume":"160","author":"Swaney","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.005_bib0315","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bib\/bbt056","article-title":"Similarity-based machine learning methods for predicting drug-target interactions: a brief review","volume":"15","author":"Ding","year":"2014","journal-title":"Brief. Bioinform."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.005_bib0320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.005_bib0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/aps.2011.210","article-title":"Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets","volume":"33","author":"Tang","year":"2012","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817313233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817313233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T10:13:57Z","timestamp":1589796837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817313233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":65,"alternative-id":["S1043661817313233"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.005","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}